Evidence map›Paper›PMID 41088961›Full record

ReviewProteins2026

Practical Outcomes From CASP16 for Users in Need of Biomolecular Structure Prediction.

Luciano A Abriata, Matteo Dal Peraro

Abstract readReview
In one paragraph

Review in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Luciano A AbriataLaboratory for Biomolecular Modeling and Protein Structure Core Facility, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL) and Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-3087-8677
Matteo Dal PeraroLaboratory for Biomolecular Modeling and Protein Structure Core Facility, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL) and Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 16th Critical Assessment of Structure Prediction benchmarked advancements in biomolecular modeling, particularly in the context of AlphaFold 2 and 3 systems. Protein monomer and domain prediction is largely solved, with barely any space for further improvements at the backbone level except for very specific details, irregular secondary structures, and mutational effects that remain challenging to predict. For protein assemblies, AF-based methods, especially when expertly guided or enhanced by servers like those from the Yang, Zheng/Zhang, and Cheng lab, show progress, though complex topologies and in particular antibody-antigen interactions are still difficult. Notably, a priori knowledge of stoichiometry significantly aids assembly prediction. Protein-ligand co-folding with AF3 demonstrated strong potential for pose prediction, outperforming many participants and some dedicated docking tools in baseline tests, but several caveats hold as discussed. Ligand affinity prediction is totally unreliable. Nucleic acid structure prediction lags considerably, heavily relying on 3D templates and expert human intervention, even AF3 showing substantial limitations. Overall, on all fronts, AF3's modeling capabilities are at or close to the state of the art; additionally, it shows slight improvements over AF2 and more detailed confidence metrics than it. We guide users on tool selection, realistic accuracy expectations, and persistent challenges, emphasizing the critical role of confidence metrics in interpreting AI-generated models.

Indexed as

Computational BiologyProteinsSoftwareAlgorithmsDatabases, ProteinHumansLigandsModels, MolecularMolecular Docking SimulationNucleic Acid ConformationProtein BindingProtein ConformationProtein FoldingLigandsProteinsalphafoldmolecular modelingstructure prediction

Identifiers

PMID41088961
PMCPMC12750028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.